Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07221019 · ClinicalTrials.gov registry record · Phase 4
Single Shot Exparel vs Catheters in Lower Extremity Trauma
A Phase 4 study of Fracture and Fracture Dislocation of Ankle Joint, sponsored by George Washington University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT07221019: Recruiting Phase 4 study of Fracture and Fracture Dislocation of Ankle Joint, sponsored by George Washington University.
NCT07221019 is a Phase 4 study of Fracture and Fracture Dislocation of Ankle Joint that is actively recruiting participants, run by George Washington University. The registered enrollment target is 90 participants, below the 4,692-participant average among 9 other Fracture trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07221019, a Phase 4 study of Fracture and Fracture Dislocation of Ankle Joint, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the use of single-shot Exparel, a long-acting local anesthestic, with the use of catheters that deliver a continuous flow of the short-acting local anesthetic ropivacaine. The comparison will be done in patients who receive preoperative adductor and sciatic nerve blocks prior to orthopedic surgery for traumatic lower extremity injury. The patients' pain will then be monitored for up to 72 hours after injection, measuring every 12 hours after injection until the 72-hour mark. Opioid consumption (measured in morphine milligram equivalents) will also be tracked over this time period.
Primary Outcome
Visual Analog Scale on a scale of 0-10 (0 is no pain and 10 is the worst pain)
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Exparel + Bupivacaine
Study Locations (1)
District of Columbia
- The George Washington University Hospital - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-09-12 |
| Est. Completion | 2029-08-11 |
| Phase | Phase 4 |
What NCT07221019 shows while recruiting
NCT07221019 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 4,692-participant average among 9 other Fracture trials with a reported enrollment target (98% lower).
The record links to 5 conditions, with Fracture appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine is the first listed.
NCT07221019 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT07221019 about?
NCT07221019 is a clinical study titled "Single Shot Exparel vs Catheters in Lower Extremity Trauma". This study will compare the use of single-shot Exparel, a long-acting local anesthestic, with the use of catheters that deliver a continuous flow of the short-acting local anesthetic ropivacaine. The comparison will be done in patients who receive preoperative adductor and sciatic nerve blocks prior...
What is the current status of trial NCT07221019?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2025-09-12. Estimated completion is 2029-08-11.
What conditions does trial NCT07221019 study?
This clinical trial studies the following conditions: Fracture, Fracture Dislocation of Ankle Joint, Fracture Leg, Fracture Femur, Fracture Lower Leg.
What interventions are being tested in trial NCT07221019?
The interventions under investigation include: Bupivacaine (DRUG), Exparel + Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT07221019?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07221019 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07221019's enrollment target sits among peer trials
90 6th of 9 higher than 4 of 9 other Fracture trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fracture trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma
RECRUITING · Phase 4
-
Methadone Versus Morphine for Orthopedic Surgery Patients
COMPLETED · Phase 4
-
Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems
RECRUITING
-
PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation
RECRUITING · Phase 3
-
Investigation Of Bioabsorbable Screws In Pediatric Orthopedic Surgery
RECRUITING · NA
-
Exactech Shoulder Post Market Clinical Follow-up Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI